DOCSLIB.ORG

Standard Operating Procedures for PET/CT: a Practical Approach for Use in Adult Oncology No

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Standard Operating Procedures for PET/CT: a Practical Approach for Use in Adult Oncology No IAEA HUMAN HEALTH SERIES No. 26 SERIES No. IAEA HUMAN HEALTH Proper cancer management requires highly accurate imaging for characterizing, staging, restaging, assessing response to therapy, prognosticating and detecting recurrence of disease. The ability to provide, in a single imaging session, detailed anatomical and metabolic/functional information has established positron emission tomography/computed tomography (PET/CT) as an indispensable imaging procedure in the management of many types of cancer. The reliability of the images acquired on a PET/CT scanner depends on the quality of the imaging technique. This publication addresses this important aspect of PET/CT imaging, namely, how to perform an 18F-fl uorodeoxyglucose (FDG) PET/CT scan in an adult patient with cancer. It provides a comprehensive overview that can be used both by new PET/CT centres in the process of starting up and by established imaging centres for updating older protocols. IAEA HUMAN HEALTH SERIES IAEA HUMAN HEALTH SERIES Standard Operating Procedures for PET/CT: A Practical Approach for Use in Adult Oncology A Practical Approach for PET/CT: Operating Procedures Standard No. 26 Standard Operating Procedures for PET/CT: A Practical Approach for Use in Adult Oncology INTERNATIONAL ATOMIC ENERGY AGENCY VIENNA ISBN 978–92–0–143710–5 ISSN 2075–3772 RELATED PUBLICATIONS IAEA HUMAN HEALTH SERIES PUBLICATIONS APPROPRIATE USE OF FDG-PET FOR THE MANAGEMENT OF CANCER PATIENTS The mandate of the IAEA human health programme originates from Article II of IAEA Human Health Series No. 9 its Statute, which states that the “Agency shall seek to accelerate and enlarge the STI/PUB/1438 (85 pp.; 2010) contribution of atomic energy to peace, health and prosperity throughout the world”. ISBN 978–92–0–101610–2 Price: €39.00 The main objective of the human health programme is to enhance the capabilities of IAEA Member States in addressing issues related to the prevention, diagnosis and PLANNING A CLINICAL PET CENTRE treatment of health problems through the development and application of nuclear IAEA Human Health Series No. 11 techniques, within a framework of quality assurance. STI/PUB/1457 (146 pp.; 2010) Publications in the IAEA Human Health Series provide information in the areas ISBN 978-92-0-104610-9 Price: €42.00 of: radiation medicine, including diagnostic radiology, diagnostic and therapeutic nuclear medicine, and radiation therapy; dosimetry and medical radiation physics; and stable QUALITY ASSURANCE FOR PET AND PET/CT SYSTEMS isotope techniques and other nuclear applications in nutrition. The publications have a IAEA Human Health Series No. 1 broad readership and are aimed at medical practitioners, researchers and other STI/PUB/1393 (145 pp; 2009) professionals. International experts assist the IAEA Secretariat in drafting and reviewing ISBN 978-92-0-103609-4 Price: €32.00 these publications. Some of the publications in this series may also be endorsed or co- sponsored by international organizations and professional societies active in the relevant STRATEGIES FOR CLINICAL IMPLEMENTATION AND QUALITY fields. MANAGEMENT OF PET TRACERS There are two categories of publications in this series: STI/PUB/1344 (197 pp.; 2009) ISBN 978-92-0-107008-1 Price: €44.00 IAEA HUMAN HEALTH SERIES Publications in this category present analyses or provide information of an A GUIDE TO CLINICAL PET IN ONCOLOGY: IMPROVING CLINICAL advisory nature, for example guidelines, codes and standards of practice, and quality MANAGEMENT OF CANCER PATIENTS assurance manuals. Monographs and high level educational material, such as graduate IAEA TECDOC Series No. 1605 texts, are also published in this series. IAEA-TECDOC-1605 (61 pp; 2008) ISBN 978-92-0-110608-7 Price: €15.00 IAEA HUMAN HEALTH REPORTS Human Health Reports complement information published in the IAEA Human THE ROLE OF PET/CT IN RADIATION TREATMENT PLANNING FOR Health Series in areas of radiation medicine, dosimetry and medical radiation physics, CANCER PATIENT TREATMENT and nutrition. These publications include reports of technical meetings, the results of IAEA TECDOC Series No. 1603 IAEA coordinated research projects, interim reports on IAEA projects, and educational IAEA TECDOC-1603 (43 pp; 2008) material compiled for IAEA training courses dealing with human health related subjects. ISBN 978-92-0-110408-3 Price: €15.00 In some cases, these reports may provide supporting material relating to publications issued in the IAEA Human Health Series. CYCLOTRON PRODUCED RADIONUCLIDES: GUIDANCE ON FACILITY DESIGN AND PRODUCTION OF [18F]FLUORODEOXYGLUCOSE (FDG) All of these publications can be downloaded cost free from the IAEA web site: IAEA Radioisotopes and Radiopharmaceuticals Series No. 3 http://www.iaea.org/Publications/index.html STI/PUB/1515 (153 pp; 2012) Further information is available from: ISBN 978-92-0-117310-2 Price: €55.00 Marketing and Sales Unit International Atomic Energy Agency RADIATION PROTECTION IN NEWER MEDICAL IMAGING TECHNIQUES: Vienna International Centre PET/CT PO Box 100 Safety Reports Series No. 58 1400 Vienna, Austria STI/PUB/1343 (41 pp; 2008) ISBN 978-92-0-106808-8 Price: €28.00 Readers are invited to provide their impressions on these publications. Information may be provided via the IAEA web site, by mail at the address given above, or by email to: [email protected]. www.iaea.org/books STANDARD OPERATING PROCEDURES FOR PET/CT: A PRACTICAL APPROACH FOR USE IN ADULT ONCOLOGY The following States are Members of the International Atomic Energy Agency: AFGHANISTAN GUATEMALA PANAMA ALBANIA HAITI PAPUA NEW GUINEA ALGERIA HOLY SEE PARAGUAY ANGOLA HONDURAS PERU ARGENTINA HUNGARY PHILIPPINES ARMENIA ICELAND POLAND AUSTRALIA INDIA PORTUGAL AUSTRIA INDONESIA AZERBAIJAN IRAN, ISLAMIC REPUBLIC OF QATAR BAHRAIN IRAQ REPUBLIC OF MOLDOVA BANGLADESH IRELAND ROMANIA BELARUS ISRAEL RUSSIAN FEDERATION BELGIUM ITALY RWANDA BELIZE JAMAICA SAUDI ARABIA BENIN JAPAN SENEGAL BOLIVIA JORDAN SERBIA BOSNIA AND HERZEGOVINA KAZAKHSTAN SEYCHELLES BOTSWANA KENYA SIERRA LEONE BRAZIL KOREA, REPUBLIC OF BULGARIA KUWAIT SINGAPORE BURKINA FASO KYRGYZSTAN SLOVAKIA BURUNDI LAO PEOPLE’S DEmOCRATIC SLOVENIA CAMBODIA REPUBLIC SOUTH AFRICA CAMEROON LATVIA SPAIN CANADA LEBANON SRI LANKA CENTRAL AFRICAN LESOTHO SUDAN REPUBLIC LIBERIA SWAZILAND CHAD LIBYA SWEDEN CHILE LIECHTENSTEIN SWITZERLAND CHINA LITHUANIA COLOMBIA LUXEMBOURG SYRIAN ARAB REPUBLIC CONGO MADAGASCAR TAJIKISTAN COSTA RICA MALAWI THAILAND CÔTE D’IVOIRE MALAYSIA THE FORMER YUGOSLAV CROATIA MALI REPUBLIC OF MACEDONIA CUBA MALTA TOGO CYPRUS MARSHALL ISLANDS TRINIDAD AND TOBAGO CZECH REPUBLIC MAURITANIA TUNISIA MAURITIUS DEMOCRATIC REPUBLIC TURKEY OF THE CONGO MEXICO UGANDA DENMARK MONACO DOMINICA MONGOLIA UKRAINE DOMINICAN REPUBLIC MONTENEGRO UNITED ARAB EMIRATES ECUADOR MOROCCO UNITED KINGDOM OF EGYPT MOZAMBIQUE GREAT BRITAIN AND EL SALVADOR MYANMAR NORTHERN IRELAND ERITREA NAMIBIA UNITED REPUBLIC ESTONIA NEPAL OF TANZANIA ETHIOPIA NETHERLANDS UNITED STATES OF AMERICA FIJI NEW ZEALAND URUGUAY FINLAND NICARAGUA UZBEKISTAN FRANCE NIGER GABON NIGERIA VENEZUELA GEORGIA NORWAY VIETNAM GERMANY OMAN YEMEN GHANA PAKISTAN ZAMBIA GREECE PALAU ZIMBABWE The Agency’s Statute was approved on 23 October 1956 by the Conference on the Statute of the IAEA held at United Nations Headquarters, New York; it entered into force on 29 July 1957. The Headquarters of the Agency are situated in Vienna. Its principal objective is “to accelerate and enlarge the contribution of atomic energy to peace, health and prosperity throughout the world’’. The following States are Members of the International Atomic Energy Agency: IAEA HUMAN Health SERIES No. 26 AFGHANISTAN GUATEMALA PANAMA ALBANIA HAITI PAPUA NEW GUINEA ALGERIA HOLY SEE PARAGUAY ANGOLA HONDURAS PERU ARGENTINA HUNGARY PHILIPPINES ARMENIA ICELAND POLAND AUSTRALIA INDIA PORTUGAL AUSTRIA INDONESIA AZERBAIJAN IRAN, ISLAMIC REPUBLIC OF QATAR BAHRAIN IRAQ REPUBLIC OF MOLDOVA BANGLADESH IRELAND ROMANIA BELARUS ISRAEL RUSSIAN FEDERATION BELGIUM ITALY RWANDA BELIZE JAMAICA SAUDI ARABIA BENIN JAPAN SENEGAL STANDARD OPERATING BOLIVIA JORDAN SERBIA BOSNIA AND HERZEGOVINA KAZAKHSTAN SEYCHELLES BOTSWANA KENYA SIERRA LEONE BRAZIL KOREA, REPUBLIC OF PROCEDURES FOR PET/CT: BULGARIA KUWAIT SINGAPORE BURKINA FASO KYRGYZSTAN SLOVAKIA BURUNDI LAO PEOPLE’S DEmOCRATIC SLOVENIA A PRACTICAL APPROACH FOR CAMBODIA REPUBLIC SOUTH AFRICA CAMEROON LATVIA SPAIN USE IN ADULT ONCOLOGY CANADA LEBANON SRI LANKA CENTRAL AFRICAN LESOTHO SUDAN REPUBLIC LIBERIA SWAZILAND CHAD LIBYA SWEDEN CHILE LIECHTENSTEIN SWITZERLAND CHINA LITHUANIA COLOMBIA LUXEMBOURG SYRIAN ARAB REPUBLIC CONGO MADAGASCAR TAJIKISTAN COSTA RICA MALAWI THAILAND CÔTE D’IVOIRE MALAYSIA THE FORMER YUGOSLAV CROATIA MALI REPUBLIC OF MACEDONIA CUBA MALTA TOGO CYPRUS MARSHALL ISLANDS TRINIDAD AND TOBAGO CZECH REPUBLIC MAURITANIA TUNISIA MAURITIUS DEMOCRATIC REPUBLIC TURKEY OF THE CONGO MEXICO UGANDA DENMARK MONACO DOMINICA MONGOLIA UKRAINE DOMINICAN REPUBLIC MONTENEGRO UNITED ARAB EMIRATES ECUADOR MOROCCO UNITED KINGDOM OF EGYPT MOZAMBIQUE GREAT BRITAIN AND EL SALVADOR MYANMAR NORTHERN IRELAND ERITREA NAMIBIA UNITED REPUBLIC ESTONIA NEPAL OF TANZANIA ETHIOPIA NETHERLANDS UNITED STATES OF AMERICA FIJI NEW ZEALAND URUGUAY FINLAND NICARAGUA UZBEKISTAN FRANCE NIGER GABON NIGERIA VENEZUELA GEORGIA NORWAY VIETNAM GERMANY OMAN YEMEN GHANA PAKISTAN ZAMBIA GREECE PALAU ZIMBABWE The Agency’s Statute was approved on 23 October 1956 by the Conference on the Statute of the IAEA held at United Nations Headquarters, New York; it entered into force on
Load more

Recommended publications
  • Epilepsy & Seizure
    Epilepsy & Seizure Journal of Japan Epilepsy Society Vol.4 No.1 (2011) pp.15-25 Original Article Usefulness of 123I-iomazenil SPECT for childhood focal epilepsies 1) 1) 1) 1) Kentaro Okamoto, MD , Hirokazu Oguni, MD , Yoshiko Hirano, MD , Makiko Osawa, MD 1Department of Pediatrics, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan Key words: focal epilepsy, children, 123I-iomazenil SPECT, epileptic foci Published online July 29, 2011 Abstract Purpose: We investigated the usefulness of obtained from visualization of IMZ-SPECT 123I-iomazenil (IMZ-) SPECT to detect epilep- images and those speculated based on a com- tic foci in children with symptomatic focal bination of clinical manifestations, EEG find- epilepsy (SFE). ings, and brain MRI. We then verified the Subjects: 21 children with SFE who under- concordance of the results between the two went IMZ-SPECT to identify the epileptic fo- methods. cus were studied. Results: There was concordance in both later- Methods: We retrospectively compared the alization and localization in 9/12 patients with localization and lateralization of epileptic foci temporal lobe epilepsy (75%), in 2/5 patients Correspondence to: Hirokazu Oguni, MD, Department of Pediatrics, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162, Japan Tel. 81-3-3353-8111, Fax. 81-3-5269-7338, [email protected] 15 Kentaro Okamoto, et al. IMZ-SPECT for childhood epilepsy with frontal lobe epilepsy (40%), and in 2/4 interictal/ictal cerebral blood flow single pho- patients with parieto-occipital lobe epilepsy ton emission computed tomography (SPECT) (50%).
    [Show full text]
  • Members | Diagnostic Imaging Tests
    Types of Diagnostic Imaging Tests There are several types of diagnostic imaging tests. Each type is used based on what the provider is looking for. Radiography: A quick, painless test that takes a picture of the inside of your body. These tests are also known as X-rays and mammograms. This test uses low doses of radiation. Fluoroscopy: Uses many X-ray images that are shown on a screen. It is like an X-ray “movie.” To make images clear, providers use a contrast agent (dye) that is put into your body. These tests can result in high doses of radiation. This often happens during procedures that take a long time (such as placing stents or other devices inside your body). Tests include: Barium X-rays and enemas Cardiac catheterization Upper GI endoscopy Angiogram Magnetic Resonance Imaging (MRI) and Magnetic Resonance Angiography (MRA): Use magnets and radio waves to create pictures of your body. An MRA is a type of MRI that looks at blood vessels. Neither an MRI nor an MRA uses radiation, so there is no exposure. Ultrasound: Uses sound waves to make pictures of the inside of your body. This test does not use radiation, so there is no exposure. Computed Tomography (CT) Scan: Uses a detector that moves around your body and records many X- ray images. A computer then builds pictures or “slices” of organs and tissues. A CT scan uses more radiation than other imaging tests. A CT scan is often used to answer, “What does it look like?” Nuclear Medicine Imaging: Uses a radioactive tracer to produce pictures of your body.
    [Show full text]
  • Imaging in Parkinson's Disease
    Clinical Medicine 2016 Vol 16, No 4: 371–5 CME MOVEMENT DISORDERS I m a g i n g i n P a r k i n s o n ’ s d i s e a s e Authors: G e n n a r o P a g a n o , A F l a v i a N i c c o l i n i B a n d M a r i o s P o l i t i s C The clinical presentation of Parkinson’s disease (PD) Abnormal intra-neuronal (Lewy bodies) and intra-neuritic is heterogeneous and overlaps with other conditions, (Lewy neurites) deposits of fibrillary aggregates are currently including the parkinsonian variant of multiple system considered the key neuropathological alterations in PD. atrophy (MSA-P), progressive supranuclear palsy (PSP) and The majority of these aggregates, mainly composed of alpha essential tremor. Imaging of the brain in patients with (α)−synuclein, are located at presynaptic level and impair ABSTRACT parkinsonism has the ability to increase the accuracy of axonal trafficking, resulting in a series of noxious events that differential diagnosis. Magnetic resonance imaging (MRI), cause neuronal damage to the substantia nigra pars compacta single photon emission computed tomography (SPECT) and with a subsequent dopaminergic denervation of the striatum. positron emission tomography (PET) allow brain imaging The cardinal motor features of PD (bradykinesia and rigidity, of structural, functional and molecular changes in vivo in with or without resting tremor) manifest after a substantial patients with PD. Structural MRI is useful to differentiate denervation of substantia nigra, which is associated with about PD from secondary and atypical forms of parkinsonism.
    [Show full text]
  • Analysis of Variations in Susceptibility and Transcriptome Responses in Tomato to Two-Spotted Spider Mite Feeding
    Western University Scholarship@Western Digitized Theses Digitized Special Collections 2011 ANALYSIS OF VARIATIONS IN SUSCEPTIBILITY AND TRANSCRIPTOME RESPONSES IN TOMATO TO TWO-SPOTTED SPIDER MITE FEEDING Ingrid Fung Follow this and additional works at: https://ir.lib.uwo.ca/digitizedtheses Recommended Citation Fung, Ingrid, "ANALYSIS OF VARIATIONS IN SUSCEPTIBILITY AND TRANSCRIPTOME RESPONSES IN TOMATO TO TWO-SPOTTED SPIDER MITE FEEDING" (2011). Digitized Theses. 3258. https://ir.lib.uwo.ca/digitizedtheses/3258 This Thesis is brought to you for free and open access by the Digitized Special Collections at Scholarship@Western. It has been accepted for inclusion in Digitized Theses by an authorized administrator of Scholarship@Western. For more information, please contact [email protected]. ANALYSIS OF VARIATIONS IN SUSCEPTIBILITY AND TRANSCRIPTOME RESPONSES IN TOMATO TO TWO-SPOTTED SPIDER MITE FEEDING SPINE TITLE Analysis of Tomato-Spider mite Interactions THESIS FORMAT Monograph BY Ingrid Fung Graduate Program in Biology A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science The School of Graduate and Postdoctoral Studies The University of Western Ontario London, Ontario, Canada © Ingrid Fung 2011 THE UNIVERSITY OF WESTERN ONTARIO SCHOOL OF GRADUATE AND POSTDOCTORAL STUDIES CERTIFICATE OF EXAMINATION Supervisor Examiners Dr. Vojislava Grbic Dr. Mark Gijzen Supervisory Committee Dr. Denis Maxwell Dr. Susanne Kohalmi Dr. Shiva Singh Dr. Priti Krishna The thesis by Ingrid Fung entitled: Analysis of Variation in Susceptibility and Transcriptome Responses of Tomato to Two-Spotted Spider Mite Feeding is accepted in partial fulfilment of the requirements for the degree of Master of Science Date Chair of the Thesis Examination Board ABSTRACT The two-spotted spider mite (Tetranychus urticae Koch) is a pest of tomatoes (Solarium lycopersicum) worldwide.
    [Show full text]
  • Brain Imaging
    Publications · Brochures Brain Imaging A Technologist’s Guide Produced with the kind Support of Editors Fragoso Costa, Pedro (Oldenburg) Santos, Andrea (Lisbon) Vidovič, Borut (Munich) Contributors Arbizu Lostao, Javier Pagani, Marco Barthel, Henryk Payoux, Pierre Boehm, Torsten Pepe, Giovanna Calapaquí-Terán, Adriana Peștean, Claudiu Delgado-Bolton, Roberto Sabri, Osama Garibotto, Valentina Sočan, Aljaž Grmek, Marko Sousa, Eva Hackett, Elizabeth Testanera, Giorgio Hoffmann, Karl Titus Tiepolt, Solveig Law, Ian van de Giessen, Elsmarieke Lucena, Filipa Vaz, Tânia Morbelli, Silvia Werner, Peter Contents Foreword 4 Introduction 5 Andrea Santos, Pedro Fragoso Costa Chapter 1 Anatomy, Physiology and Pathology 6 Elsmarieke van de Giessen, Silvia Morbelli and Pierre Payoux Chapter 2 Tracers for Brain Imaging 12 Aljaz Socan Chapter 3 SPECT and SPECT/CT in Oncological Brain Imaging (*) 26 Elizabeth C. Hackett Chapter 4 Imaging in Oncological Brain Diseases: PET/CT 33 EANM Giorgio Testanera and Giovanna Pepe Chapter 5 Imaging in Neurological and Vascular Brain Diseases (SPECT and SPECT/CT) 54 Filipa Lucena, Eva Sousa and Tânia F. Vaz Chapter 6 Imaging in Neurological and Vascular Brain Diseases (PET/CT) 72 Ian Law, Valentina Garibotto and Marco Pagani Chapter 7 PET/CT in Radiotherapy Planning of Brain Tumours 92 Roberto Delgado-Bolton, Adriana K. Calapaquí-Terán and Javier Arbizu Chapter 8 PET/MRI for Brain Imaging 100 Peter Werner, Torsten Boehm, Solveig Tiepolt, Henryk Barthel, Karl T. Hoffmann and Osama Sabri Chapter 9 Brain Death 110 Marko Grmek Chapter 10 Health Care in Patients with Neurological Disorders 116 Claudiu Peștean Imprint 126 n accordance with the Austrian Eco-Label for printed matters.
    [Show full text]
  • Nuclear Medicine Imaging in Neuroblastoma: Current Status and New Developments
    Journal of Personalized Medicine Review Nuclear Medicine Imaging in Neuroblastoma: Current Status and New Developments Atia Samim 1,2, Godelieve A.M. Tytgat 1, Gitta Bleeker 3, Sylvia T.M. Wenker 1,2, Kristell L.S. Chatalic 1,2, Alex J. Poot 1,2, Nelleke Tolboom 1,2, Max M. van Noesel 1 , Marnix G.E.H. Lam 2 and Bart de Keizer 1,2,* 1 Princess Maxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, The Netherlands; [email protected] (A.S.); [email protected] (G.A.M.T.); [email protected] (S.T.M.W.); [email protected] (K.L.S.C.); [email protected] (A.J.P.); [email protected] (N.T.); [email protected] (M.M.v.N.) 2 Department of Radiology and Nuclear Medicine, University Medical Center Utrecht/Wilhelmina Children’s Hospital, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands; [email protected] 3 Department of Radiology and Nuclear Medicine, Northwest Clinics, Wilhelminalaan 12, 1815 JD Alkmaar, The Netherlands; [email protected] * Correspondence: [email protected]; Tel.: +31-887-571-794 Abstract: Neuroblastoma is the most common extracranial solid malignancy in children. At diagnosis, approximately 50% of patients present with metastatic disease. These patients are at high risk for refractory or recurrent disease, which conveys a very poor prognosis. During the past decades, Citation: Samim, A.; Tytgat, G.A.M.; nuclear medicine has been essential for the staging and response assessment of neuroblastoma. 123 123 Bleeker, G.; Wenker, S.T.M.; Currently, the standard nuclear imaging technique is meta-[ I]iodobenzylguanidine ([ I]mIBG) Chatalic, K.L.S.; Poot, A.J.; whole-body scintigraphy, usually combined with single-photon emission computed tomography Tolboom, N.; van Noesel, M.M.; with computed tomography (SPECT-CT).
    [Show full text]
  • (18F-FDG) Uptake for PET/CT in Normal Organs
    www.nature.com/scientificreports OPEN Efects of blood glucose level on 18F fuorodeoxyglucose (18F- FDG) uptake for PET/CT in normal Received: 24 October 2017 Accepted: 18 January 2018 organs: an analysis on 5623 Published: xx xx xxxx patients Clarice Sprinz1,2, Matheus Zanon 3,4, Stephan Altmayer3,4, Guilherme Watte 3, Klaus Irion 5, Edson Marchiori 6 & Bruno Hochhegger 2,3,4 Our purpose was to evaluate the efect of glycemia on 18F-FDG uptake in normal organs of interest. The infuences of other confounding factors, such as body mass index (BMI), diabetes, age, and sex, on the relationships between glycemia and organ-specifc standardized uptake values (SUVs) were also investigated. We retrospectively identifed 5623 consecutive patients who had undergone clinical PET/ CT for oncological indications. Patients were stratifed into groups based on glucose levels, measured immediately before 18F-FDG injection. Diferences in mean SUVmax values among glycemic ranges were clinically signifcant only when >10% variation was observed. The brain was the only organ that presented a signifcant inverse relationship between SUVmax and glycemia (p < 0.001), even after controlling for diabetic status. No such diference was observed for the liver or lung. After adjustment for sex, age, and BMI, the association of glycemia with SUVmax was signifcant for the brain and liver, but not for the lung. In conclusion, the brain was the only organ analyzed showing a clinically signifcant relationship to glycemia after adjustment for potentially confounding variables. The lung was least afected by the variables in our model, and may serve as an alternative background tissue to the liver.
    [Show full text]
  • Initial Clinical Comparison of 18F-Florbetapir and 18F-FDG PET in Patients with Alzheimer Disease and Controls
    Journal of Nuclear Medicine, published on May 10, 2012 as doi:10.2967/jnumed.111.099606 Initial Clinical Comparison of 18F-Florbetapir and 18F-FDG PET in Patients with Alzheimer Disease and Controls Andrew B. Newberg1, Steven E. Arnold2, Nancy Wintering1, Barry W. Rovner1, and Abass Alavi2 1Thomas Jefferson University and Hospital, Philadelphia, Pennsylvania; and 2University of Pennsylvania, Philadelphia, Pennsylvania The purpose of this study was to determine how clinical inter- Alzheimer disease (AD) is a brain disorder of older pretations of the 18F-amyloid tracer florbetapir compares diagnos- adults, with symptoms of progressive decline in memory 18 tically with F-FDG PET when evaluating patients with Alzheimer and other cognitive functions. A definitive diagnosis of AD disease (AD) and controls. Methods: Nineteen patients with a clin- ical diagnosis of AD and 21 elderly controls were evaluated with can be established only by demonstrating the presence of both 18F-florbetapir and 18F-FDG PET scans. Scans were inter- abundant senile plaques and neurofibrillary tangles in post- preted together by 2 expert readers masked to any case informa- mortem brain sections (1,2). During life, most patients are tion and were assessed for tracer binding patterns consistent with diagnosed by clinical criteria that imperfectly track with AD. The criteria for interpreting the 18F-florbetapir scan as positive postmortem pathologic findings. The criteria for the diagno- for AD was the presence of binding in the cortical regions relative to sis of AD were defined by the Working Group of the Na- the cerebellum. 18F-FDG PET scans were interpreted as positive if they displayed the classic pattern of hypometabolism in the tem- tional Institute of Neurologic and Communicative Disorders poroparietal regions.
    [Show full text]
  • Leo's Lulu MASTER
    TOM SWIFT and the Cometary Reclamation BY Leo L. Levesque & Thomas Hudson Book two in the trilogy that began with Tom Swift and His Space Battering Ram A Joint Levesque Publishing Empire / Thackery Fox & Assoc. Publication Made in The United States on America ©opyright 2014 by the authors of this book (Leo L. Levesque and Thomas Hudson). While some of the characters in this story have appeared in other books and collections of books, published by other entities, it is believed that all have fallen into Public Domain status. Fair use under U.S. Copyright Law provisions for “parodies” is claimed for their inclusion in this story. The book authors retain all ownership and copyrights to new or substantially altered characters, previously unpublished locations and situations, and to their contributions to this book and to the total story. The characters Damon Swift, Anne Swift and Bashalli Prandit were created by Scott Dickerson and are used through his incredible largess and understanding that they are superior to those they replaced. This book is a work of fan fiction. It is not claimed to be part of any previously published adventures of the main characters. It has been self-published and is not intended to supplant any authored works attributed to the pseudononomous author, Victor Appleton II, or to claim the rights from any legitimate publishing entity. 2 Tom Swift and the Cometary Reclaimation By Leo L. Levesque and Thomas Hudson After Tom saves the world from the rouge comet meant to wreck havoc on the Earth, the Swifts work along with Harlan Ames, recently elevated to head of the former Master’s lunar colony, to see what the situation might now be.
    [Show full text]
  • Relative Influence of Dietary Protein and Energy Contents on Lysine
    British Journal of Nutrition, page 1 of 15 doi:10.1017/S0007114517003300 © The Authors 2017 Relative influence of dietary protein and energy contents on lysine requirements and voluntary feed intake of rainbow trout fry Mélusine Van Larebeke*, Guillaume Dockx, Yvan Larondelle and Xavier Rollin* Institut des Sciences de la Vie, Université catholique de Louvain, Place Croix du Sud 2/L7.05.08, 1348 Louvain-la-Neuve, Belgium (Submitted 7 January 2017 – Final revision received 29 October 2017 – Accepted 30 October 2017) Abstract The effect of dietary digestible protein (DP) and/or digestible energy (DE) levels on lysine (Lys) requirements, Lys utilisation efficiency and voluntary feed intake (VFI) were studied in rainbow trout fry when Lys was the first limiting indispensable amino acid or in excess in the diet. Two trials were conducted at 11·6°C with eighty-one experimental diets, containing 280 g DP/kg DM (low protein (LP), trial 1), 600 g DP/kg DM (high protein (HP), trial 1) or 440 g DP/kg DM (medium protein (MP), trial 2), 17 MJ DE/kg (low energy (LE)), 19·5 MJ DE/kg (medium energy (ME)) or 22 MJ DE/kg (high energy (HE)), and nine Lys levels from deeply deficient to large excess (2·3–36 g/kg DM). Each diet was given to apparent satiety to one group of fifty fry (initial body weight 0·85 g) for 24 (MP diets, trial 2) or 30 (LP and HP diets, trial 1) feeding days. Based on N gain data fitted with the broken-line model, the relative Lys requirement was significantly different with the dietary DP level, from 13·3–15·7to22·9–26·5 g/kg DM for LP and HP diets, respectively, but did not significantly change with the DE level for a same protein level.
    [Show full text]
  • ICD-10: Clinical Concepts for Internal Medicine
    ICD-10 Clinical Concepts for Internal Medicine ICD-10 Clinical Concepts Series Common Codes Clinical Documentation Tips Clinical Scenarios ICD-10 Clinical Concepts for Internal Medicine is a feature of Road to 10, a CMS online tool built with physician input. With Road to 10, you can: l Build an ICD-10 action plan customized l Access quick references from CMS and for your practice medical and trade associations l Use interactive case studies to see how l View in-depth webcasts for and by your coding selections compare with your medical professionals peers’ coding To get on the Road to 10 and find out more about ICD-10, visit: cms.gov/ICD10 roadto10.org ICD-10 Compliance Date: October 1, 2015 Official CMS Industry Resources for the ICD-10 Transition www.cms.gov/ICD10 1 Table Of Contents Common Codes • Abdominal Pain • Headache • Acute Respiratory Infections • Hypertension • Back and Neck • Pain in Joint Pain (Selected) • Pain in Limb • Chest Pain • Other Forms of • Diabetes Mellitus w/o Heart Disease Complications Type 2 • Urinary Tract • General Medical Examination Infection, Cystitis Clinical Documentation Tips • Acute Myocardial • Diabetes Mellitus, Infarction (AMI) Hypoglycemia and • Hypertension Hyperglycemia • Asthma • Abdominal Pain and Tenderness • Underdosing Clinical Scenarios • Scenario 1: Follow-Up: • Scenario: Cervical Kidney Stone Disc Disease • Scenario 2: Epigastric Pain • Scenario: Abdominal Pain • Scenario 3: Diabetic • Scenario: Diabetes Neuropathy • Scenario: ER Follow Up • Scenario 4: Poisoning • Scenario: COPD with
    [Show full text]
  • Breast CT: a New Alternative to Mammography University of California, Davis (UC Davis)
    Breast CT: A New Alternative To Mammography University of California, Davis (UC Davis) Computed tomography (CT) is used extensively to identify tumors and other abnormalities in the brain, abdomen and pelvis. In contrast to medical X-rays, which produce a single-layer 2-D image, a CT scan records hundreds of images of multiple tissue layers and assembles them into a 3-D representation. A team working at University of California Davis Cancer Center has developed a breast CT device they believe provides a more comfortable and potentially more sensitive alternative to X-ray based mammography to detect breast cancer. The breast CT device, currently in a Phase II investigational trial, is the invention of Drs. John Boone, professor of radiology at UC-Davis, and Thomas R. Nelson, professor of radiology at University of California, San Diego. CT has not typically been applied to breast cancer detection because of concerns over the radiation dose required. The inventors solved this problem by designing a CT device that scans each breast while the patient lies face down on a special table. The radiation exposure in the breast is equivalent to that of a traditional mammogram, and the thoracic cavity is not irradiated at all, as it would be in a conventional CT scanner. The first 21 patients in the ongoing clinical trial reported that the CT breast scan, which does not require breast compression, caused them less discomfort than mammography. The CT detected 19 of the 21 tumors initially identified by mammography, and Dr. Lindfors believes the prototype machine and method of scanning can be modified to improve on this detection rate.
    [Show full text]